Plain-English translation of NCT06418204 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The COSMIC study is investigating whether cannabis and cannabinoid products (like CBD and THC) can help manage cancer-related symptoms in people newly diagnosed with breast, colorectal, lung, melanoma, or lymphoma cancer. Researchers will follow participants for one year while they receive standard cancer treatment, collecting monthly survey data and reviewing medical records to understand both the potential benefits and any harms of using these products during cancer care.
Cancer patients often struggle with symptoms like pain, nausea, anxiety, and sleep problems. While some patients turn to cannabis or cannabinoid products to manage these symptoms, doctors need solid information about whether this treatment actually helps and whether it's safe to use alongside chemotherapy or immunotherapy.
You likely qualify if…
You likely don't qualify if…
Over one year, you will complete monthly online surveys about your symptoms, cannabis or cannabinoid use, and how you're feeling. The research team will also review your medical records to track your cancer treatment and health changes. All surveys can be completed from home, your clinic, or any location with internet access — fitting into your existing cancer care routine.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States